跳至主要内容
临床试验/JPRN-UMIN000000685
JPRN-UMIN000000685已完成未知

Stanford type B aortic dissection patients with normally hypotensive medical therapy and pitavastatin treatment effect. - Stanford type B aortic dissection patients with pitavastatin treatment trial (STANP trial)

Cardiovascular Surgery, Tohoku University, Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2007年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Patients with the total diameter of descending aorta (minor axis) by CT angiography more than 50mm. (2)Marfan's syndrome patients (3)Patients with continuous pain. (4)Patients with unstable vital signs. (5)Patients with signs or symptoms of organ ischemia (6)Fasting serum levels of TC >/= 250 mg/dL. (7)Known hypersensitivity or history of clinically significant adverse reactions to any component of study drugs. (8)Patients with hepatopathy (ALT >/=100 IU/L) or biliary obstruction with the following conditions - acute hepatitis, acute exacerbation of chronic hepatitis, hepatic cirrhosis, hepatoma, jaundice. (9)Pregnant, possibly pregnant, or lactating. (10)Patients with significant renal dysfunction (serum creatinine >/= 2.0 mg/dL) or renal dialysis. (11)Patient who is judged by the investigator to be inappropriate for inclusion in the study.

研究者

发起方
Cardiovascular Surgery, Tohoku University, Graduate School of Medicine

相似试验